Related Experiment Video
Updated: Dec 18, 2025

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
Published on: October 20, 2023
Sialic Acid Metabolic Engineering of Breast Cancer Cells Interferes with Adhesion and Migration
Manimozhi Nagasundaram1, Rüdiger Horstkorte1, Vinayaga Srinivasan Gnanapragassam1
1Institute for Physiological Chemistry, Medical Faculty, Martin-Luther-University; Halle-Wittenberg, 06120 Halle (Saale), Germany.
Abstract:
Breast cancer is the most frequent cancer diagnosed in women and the second most common cancer-causing death worldwide. The major problem around the management of breast cancer is its high heterogeneity and the development of therapeutic resistance. Therefore, understanding the fundamental breast cancer biology is crucial for better diagnosis and therapy. Protein sialylation is a key posttranslational modification of glycoproteins, which is also involved in tumor progression and metastasis. Increased expression of sialic acids (Sia) can interfere in receptor-ligand interactions and might protect tumor cells from the immune system. Furthermore, Sia content on the cell membrane plays a role in cancer resistance towards chemo- and radiation therapy. In this study, we glycoengineered MCF-7 breast cancer cells using a series of non-natural Sia precursors, which are prolonged in their acyl side chain. We observed a significant reduction in the natural Sia (N-Acetylneuraminic acid) expression after cultivation of MCF-7 cells with these Sia precursors. In addition, the expression of polySia, a unique glycosylation of the neural cell adhesion molecule NCAM, which interferes with cell adhesion, was decreased. We conclude that sialic acid engineering i) opens up novel opportunities to study the biological role of Sia in breast cancer and ii) provides a toolbox to examine the sialic acid-dependent complex cellular alterations in breast cancer cell biology.
Insights
This study engineered breast cancer cells to reduce sialic acids (Sia), a molecule linked to tumor progression and therapy resistance. The findings offer new ways to study and potentially treat breast cancer by altering cell surface sugars.
Area of Science:
- Biochemistry
- Glycobiology
- Cancer Biology
Background:
- Breast cancer is a leading cause of death in women, characterized by heterogeneity and therapeutic resistance.
- Protein sialylation, involving sialic acids (Sia), is implicated in tumor progression, metastasis, and resistance to cancer therapies.
- Understanding breast cancer biology, including sialylation, is crucial for improved diagnosis and treatment strategies.
Purpose of the Study:
- To investigate the effects of glycoengineering breast cancer cells with non-natural sialic acid precursors.
- To explore the potential of modulating sialic acid expression for therapeutic strategies in breast cancer.
- To examine the impact of altered sialic acid levels on cancer cell biology and resistance mechanisms.
Main Methods:
- MCF-7 breast cancer cells were glycoengineered using non-natural sialic acid precursors with extended acyl side chains.
- The expression levels of natural sialic acid (N-Acetylneuraminic acid) were quantified after precursor treatment.
- The expression of polysialic acid (polySia) on NCAM was assessed to evaluate changes in cell adhesion-related glycosylation.
Main Results:
- Cultivation of MCF-7 cells with non-natural Sia precursors led to a significant reduction in natural N-Acetylneuraminic acid expression.
- The expression of polySia, a glycosylation affecting cell adhesion, was decreased in the engineered cells.
- Sialic acid engineering demonstrated a modulation of key glycosylation pathways in breast cancer cells.
Conclusions:
- Sialic acid engineering provides a novel approach to study the biological functions of Sia in breast cancer.
- This glycoengineering method offers a valuable toolset for examining complex, Sia-dependent cellular alterations in breast cancer.
- Modulating sialic acid expression may present new avenues for overcoming therapeutic resistance in breast cancer.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Chemotaxis and Direction of Cell Migration
Selectins

